The Kentucky Viral Hepatitis Treatment Study

NCT03949764 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

374

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Opioid-Related Disorders
Injection Drug Use

Interventions

DRUG: Sofosbuvir/velpatasvir (Epclusa®)

Sponsor

Jennifer Havens

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]